Olsalazine

This classification denotes a nonsteroidal antiinflammatory drug with the molecular formula C14H10N2O6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier ULS5I8J03O, chemically known as 1,2,3,4,10,14b-hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)benzazepine but generally known as olsalazine, which bears US NIH Compound Identifier 4205. European Medicines Agency schedules Olsalazine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09436MIG. The term OLSALAZINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 39, No. 5, 1985, List 25). World Health Organization schedules olsalazine in its Anatomical Therapeutic Chemical (ATC) Classification. OLSALAZINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule olsalazine under HS 32041200 and SITC 53112. As of Q4 2014, OLSALAZINE remains the US FDA Preferred Term for this commodity. Olsalazine bears US NLM identifiers UMLS ID C0069454 and NCI Concept Code C1176. SMILES: N12C(CN(CC1)C)C1C(CC3C2NCCC3)CCCC1.